Comparative outcomes with low-dose and standard-dose immune checkpoint inhibitors in microsatellite stable advanced gastric/gastroesophageal adenocarcinoma☆

Background: The combination of chemotherapy and immune checkpoint inhibitors (ICIs) is usually considered standard in advanced gastric/gastroesophageal adenocarcinoma (GC) with combined positive score (CPS) 6≥5. Methods: Data of patients with microsatellite stable advanced GCs receiving chemotherapy...

Descrición completa

Detalles Bibliográficos

Principais autores:	A. Ramaswamy, V. Shenoy, A. Bahl, A. Rauthan, V.M. Krishna, V. Talwar, V. Agarwala, A. Kapoor, R. Pinninti, M. Sharma, S.J. Rajappa, N. Rohatgi, A. Khan, A. Jain, U. Batra, R.K. Kaushal, M.V. Chandrakanth, B. Sansar, A. Gupta, P. Bhargava, V. Ostwal
Formato:	Artigo
Idioma:	Inglês
Publicado:	Elsevier 2026-03-01
Series:	ESMO Gastrointestinal Oncology
Assuntos:	low-dose immune checkpoint inhibitors CPS advanced gastric adenocarcinoma
Acceso en liña:	http://www.sciencedirect.com/science/article/pii/S2949819826000026
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!